J&J says delaying rollout of Covid-19 vaccine in Europe
Coronavirus chronicle
13 April, 2021, 07:55 pm
Last modified: 13 April, 2021, 07:54 pm
US federal health agencies on Tuesday recommended pausing the use of the Covid-19 vaccine as six women under 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic
Photo: Collected
Johnson & Johnson said on Tuesday it would delay the rollout of its Covid-19 vaccine in Europe and was reviewing cases of extremely rare blood clots in people after they received the shot with European health authorities.
US federal health agencies on Tuesday recommended pausing the use of the Covid-19 vaccine as six women under 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.